Gosset Ozmosis Research General Information
Ozmosis Research specializes in the design and management of Phase I–III clinical trials with deep expertise in oncology. The company operates as a social enterprise CRO spun out from Princess Margaret Cancer Centre. It partners with pharmaceutical/biotech companies and academic investigators to expedite trial initiation and patient recruitment across North America, Europe, and Australia. Its leadership includes recognized experts from leading Canadian research institutions. The company does not have its own drug pipeline but has an extensive track record supporting complex cancer studies including those involving novel molecular targeted therapies.
Contact Information
Canada
Drug Pipeline
No pipeline data available
Key Partnerships
Collaborates closely with Princess Margaret Cancer Centre, Strong relationships with sites across North America/EU/Australia, Partnerships are typically project-based with pharma/biotech sponsors.
Ozmosis Research Funding
No funding data available